More than 2 decades of Professional Experience in Pre-clinical, Clinical, Medical Affairs, Drug Safety and Post-Marketing Research of Investigational Medical Compounds, Product Launch, and LCM of Approved products.

Doctor  Robert Imani is a highly experienced medical professional with significant expertise in the development and approval of cancer drugs. Throughout his career, he has played a critical role in guiding pharmaceutical companies through the complex process of getting cancer drugs through FDA approval.

With his deep understanding of the preclinical and clinical testing requirements, Doctor Imani has helped to design and execute effective preclinical and clinical trials that have led to the successful approval of numerous cancer drugs. His expertise in navigating the complex regulatory landscape of the FDA has also been invaluable to drug developers seeking approval for their products.

Through his years of experience in this area, Doctor Robert Iman i has gained a keen insight into the challenges and opportunities involved in developing and bringing cancer drugs to market. His commitment to excellence and his dedication to advancing the field of cancer treatment have made him a highly respected authority in this critical area of medical research.